Wednesday, July 16 14:14:24
Abbott Laboratories reported better-than-expected second-quarter earnings on Wednesday, helped by improved profit margins for its medical diagnostics and vascular products businesses.
The company earned $466 million, or 30 cents per share, in the quarter. That compared with $476 million, or 30 cents, in the year-earlier period, when Abbott took charges for cost-saving initiatives and other expenses.
Excluding special items, Abbott earned 54 cents per share. Analysts, on average, expected 51 cents.
Sales rose 1.9 percent to $5.55 billion, a bit above Wall Street estimates of $5.52 billion.
"Our gross margins were better than some expected due to underlying improvement in diagnostics and vascular" products, company spokesman Scott Stoffel said.
The suburban Chicago-based company raised its full-year profit forecast to between $2.19 and $2.29 per share, from $2.16 to $2.26 per share.
Abbott shares rose 2.5 percent to $42.20 in premarket trading. (Reuters)
For more visit: www.businessworld.com